289 related articles for article (PubMed ID: 10082055)
1. The clinical efficacy of paremyd with and without dapiprazole in subjects with light and dark brown irides.
Anicho UM; Cooper J; Feldman J; Jaanus SD; Dignam K
Optom Vis Sci; 1999 Feb; 76(2):94-101. PubMed ID: 10082055
[TBL] [Abstract][Full Text] [Related]
2. Pupillary dilation and funduscopy with 1.0% hydroxyamphetamine plus 0.25% tropicamide (Paremyd) versus tropicamide (0.5 or 1.0%) as a function of iris and skin pigmentation, and age.
Cooper J; Feldman JM; Jaanus SD; Appleman W; Appel S; Horn D
J Am Optom Assoc; 1996 Nov; 67(11):669-75. PubMed ID: 8979660
[TBL] [Abstract][Full Text] [Related]
3. Comparison of efficacy and tolerance between 1% hydroxyamphetamine plus 0.25% tropicamide (Paremyd) and 0.5% tropicamide combined with 2.5% phenylephrine.
Zeise MM; McDougall BW; Bartlett JD; Corliss D; Mitten L
J Am Optom Assoc; 1996 Nov; 67(11):681-9. PubMed ID: 8979662
[TBL] [Abstract][Full Text] [Related]
4. The effect of dapiprazole on accommodative amplitude in eyes dilated with 0.5 percent tropicamide.
Nyman N; Reich L
J Am Optom Assoc; 1993 Sep; 64(9):625-8. PubMed ID: 7901257
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of dapiprazole with hydroxyamphetamine hydrobromide and tropicamide.
Johnson ME; Molinari JF; Carter J
J Am Optom Assoc; 1993 Sep; 64(9):629-33. PubMed ID: 7901258
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of dapiprazole.
Johnson ME; Molinari JF
Optom Vis Sci; 1993 Oct; 70(10):818-21. PubMed ID: 7902553
[TBL] [Abstract][Full Text] [Related]
7. Dapiprazole's effect upon accommodative recovery: is it due entirely to changes in depth of field?
Molinari JF; Carter JH; Johnson ME
Optom Vis Sci; 1995 Aug; 72(8):552-6. PubMed ID: 8539022
[TBL] [Abstract][Full Text] [Related]
8. The clinical efficacy of Rev-Eyes in reversing the effects of pupillary dilation.
Connor CG; Campbell JB; Tirey WW
J Am Optom Assoc; 1993 Sep; 64(9):634-6. PubMed ID: 7901259
[TBL] [Abstract][Full Text] [Related]
9. Dapiprazole clinical efficiency for counteracting tropicamide 1%.
Molinari JF; Johnson ME; Carter J
Optom Vis Sci; 1994 May; 71(5):319-22. PubMed ID: 7915025
[TBL] [Abstract][Full Text] [Related]
10. Effect of proparacaine on tropicamide-induced mydriasis.
Siderov J; Chuang SM; Ian K; Prassinos G; Tziortzi E; Wong JY
Optom Vis Sci; 1997 Dec; 74(12):1039-43. PubMed ID: 9423996
[TBL] [Abstract][Full Text] [Related]
11. Cycloplegia in African-American children.
Kleinstein RN; Mutti DO; Manny RE; Shin JA; Zadnik K
Optom Vis Sci; 1999 Feb; 76(2):102-7. PubMed ID: 10082056
[TBL] [Abstract][Full Text] [Related]
12. Combination cyclopentolate and phenylephrine for mydriasis in premature infants with heavily pigmented irides.
Khoo BK; Koh A; Cheong P; Ho NK
J Pediatr Ophthalmol Strabismus; 2000; 37(1):15-20. PubMed ID: 10714690
[TBL] [Abstract][Full Text] [Related]
13. Effects of dapiprazole on the reversal of pharmacologically induced mydriasis.
Nyman N; Keates EU
Optom Vis Sci; 1990 Sep; 67(9):705-9. PubMed ID: 1978275
[TBL] [Abstract][Full Text] [Related]
14. Dose-response study of dapiprazole HCl in the reversal of mydriasis induced by 2.5% phenylephrine.
Hogan TS; McDaniel DD; Bartlett JD; Hart KK; Paggiarino DA
J Ocul Pharmacol Ther; 1997 Aug; 13(4):297-302. PubMed ID: 9261765
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the effects on pupil size and accommodation of three regimens of topical dapiprazole.
Wilcox CS; Heiser JF; Crowder AM; Wassom NJ; Katz BB; Dale JL
Br J Ophthalmol; 1995 Jun; 79(6):544-8. PubMed ID: 7626570
[TBL] [Abstract][Full Text] [Related]
16. Comparison of mydriatic regimens used in screening for retinopathy of prematurity in preterm infants with dark irides.
Chew C; Rahman RA; Shafie SM; Mohamad Z
J Pediatr Ophthalmol Strabismus; 2005; 42(3):166-73. PubMed ID: 15977870
[TBL] [Abstract][Full Text] [Related]
17. The mydriatic effect of tropicamide on light and dark irides.
Dillon JR; Tyhurst CW; Yolton RL
J Am Optom Assoc; 1977 May; 48(5):653-8. PubMed ID: 893935
[TBL] [Abstract][Full Text] [Related]
18. Dapiprazole: will it affect the standard of care for pupillary dilation?
Bartlett JD; Classé JG
Optom Clin; 1992; 2(4):113-20. PubMed ID: 1363078
[TBL] [Abstract][Full Text] [Related]
19. [Clinical use of mydriasis with 10% phenylephrine and its antagonism by 0.5% dapiprazole].
Schimidbauer JM; Höh H; Franke G; Petsch E; Siegmund W
Ophthalmologe; 1999 Mar; 96(3):182-6. PubMed ID: 10234966
[TBL] [Abstract][Full Text] [Related]
20. A pupillographic evaluation of a phenylephrine HCl 5%-tropicamide 0.8% combination mydriatic.
Kergoat H; Lovasik JV; Doughty MJ
J Ocul Pharmacol; 1989; 5(3):199-216. PubMed ID: 2625616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
